Status:

WITHDRAWN

Fraxel Laser for Alopecia

Lead Sponsor:

Northwestern University

Conditions:

Alopecia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a pilot study to evaluate the effect of the 1550 nm fractional erbium-glass laser in patients with nonscarring alopecias. Participants currently living in the Chicago metropolitan area and mee...

Eligibility Criteria

Inclusion

  • Males and females ≥ 18 years old
  • Subjects are in good health as judged by the investigator.
  • Diagnosed by a dermatologist with mild to moderate androgenetic alopecia or alopecia areata.
  • Subject is seeking treatment for alopecia.
  • Subject has never previously used finasteride or minoxidil or has consistently used finasteride or minoxidil for at least 1 year.
  • Subjects who are willing and have the ability to understand and provide informed consent for participation in the study and are able to communicate with the investigator.

Exclusion

  • Evidence of another skin condition affecting the treatment area that would interfere with clinical assessments.
  • Subjects who are unwilling to avoid initiating treatment with minoxidil or finasteride for the duration of the study; or in subjects who have been treated with minoxidil or finasteride for at least 1 year, unwilling to avoid changes in the dosing regimen of these medications for the duration of the study.
  • Willing to refrain from washing hair or using hair product 24 hours before and after treatment visits
  • History of recurrent facial or labial herpes simplex infection
  • History of hypertrophic scars or keloids
  • Subjects who have any requirement for the use of local or systemic steroids or other immunosuppressive agent
  • Pregnant or breast feeding
  • Uncooperative patients or patients with neurological disorders who are incapable of following directions or who are predictably unwilling to return for follow-up examinations.
  • Subjects who are unable to understand the protocol or give informed consent.

Key Trial Info

Start Date :

April 24 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 24 2019

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03284021

Start Date

April 24 2019

End Date

April 24 2019

Last Update

December 6 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwestern University Department of Dermatology

Chicago, Illinois, United States, 60611